麻豆社

听

听

Cancer incidence rate听refers to the number of new cancers cases occurring in a specified population during a given year, expressed as the number of cancer cases per 100,000 population.^1听

In 2018, the UK ranked 5^th听amongst the 31 European countries studied for the incidence of Hodgkin lymphoma, with 3 people in every 100,000 being diagnosed with the condition (ranging from 1 case per 100,000 people in Romania to 7 per 100,000 people in Greece).

The UK's incidence rate for this cancer type was similar to the European average.

Downloads:

• Download graphs听|听download data听 |听download complete zip听

Note:

• For this cancer type there is no information available on incidence at a country level for 1995

Reference for text:

1. 听

References for graphs:

• ECIS (European Cancer Information System) https://ecis.jrc.ec.europa.eu/. Incidence and mortality estimates 2018听
• ECIS (European Cancer Information System) https://ecis.jrc.ec.europa.eu/. Incidence and mortality historical data

Cancer Deaths

Cancer mortality rate refers to the number of deaths caused by cancer occurring in a specified population during a given year, expressed as the number of cancer deaths per 100,000 population.²

In 2018, the UK ranked 5^th听amongst the 31 European countries studied for the mortality of Hodgkin lymphoma, with 1 in every 100,000 people dying from the condition (ranging from less than 1 death per 100,000 people in Austria to 2 per 100,000 people in Greece).

The UK's mortality rate for this cancer type was similar to the European average.

Downloads:

• Download graphs听|听download data听 |听download complete zip听

Note:

• For this cancer type there is no information available on mortality at a country level for 1995

Reference for text:

2.

References for graphs:

• ECIS (European Cancer Information System) https://ecis.jrc.ec.europa.eu/. Incidence and mortality estimates 2018

Survival refers to the percentage of people that were diagnosed with cancer in a given year and who are still alive after a certain period of time (here defined as 5 years or more after being diagnosed).³

Between 2010 and 2014, the UK ranked 13^th听amongst the 28 European countries studied for the 5 year survival post-diagnosis of blood cancers, with 65% of people surviving 5 years or more after being diagnosed with these cancer types (ranging from 40% survival in Romania to 72% in Switzerland).

Downloads:

Notes:

• There is no country level data for these cancer types between 1995 and 1999
• There is no European average for 5-year survival because data for Greece, Hungary and Luxembourg is lacking
• Survival data was only collected for leukaemia, Non-Hodgkin lymphoma, Hodgkin lymphoma and multiple myeloma听for all countries
• The latest data collected by IHE was for the 2010-2014 5-year period

Reference for text:

3.

References for graphs:

• 听

Uptake of Cancer Medicines

Note: Data pertaining to the uptake of cancer medicines was not available for Hodgkin lymphoma medicines across all European countries examined by IHE, in 2018.